Caio is part of the Biozeus’ R&D team since 2014. He is currently in charge of coordinating the scientific activities regarding project BZ043 (diabetes and obesity) as well as leading the elaboration of patenting strategies related to all of the assets in the pipeline. Caio has also significantly contributed to the analysis of new projects potentially interesting for the company. Outside Biozeus, Caio is a Ph.D. candidate at the Institute of Economics of the Federal University of Rio de Janeiro (UFRJ), where he is studying IP and innovation in the pharmaceutical industry.
The selection of commercially viable drug candidates and advancing their development
toward worldwide markets is a complex and challenging task that requires people with a broad
range of different qualifications and drug development know-how.